U.S. Markets closed

Sunshine Heart, Inc. (SSH)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.61-0.02 (-2.47%)
At close: 4:00PM EDT
People also watch
IDXGRNVANVCNETRMTNXP

Sunshine Heart, Inc.

12988 Valley View Road
Eden Prairie, MN 55344
United States
952-345-4200
http://www.sunshineheart.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees29

Key Executives

NameTitlePayExercisedAge
Mr. John L. ErbChairman, Chief Exec. Officer and Pres613.75kN/A68
Ms. Claudia Napal DraytonChief Financial Officer and Sec.327.21kN/A49
Mr. David LernerSr. VP of R&D and OperationsN/AN/AN/A
Mr. Gordon S. Weber J.D.VP and Gen. CounselN/AN/AN/A
Ms. Sandra EayrsVP of HRN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sunshine Heart, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Sunshine Heart, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Corporate Governance

Sunshine Heart, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.